Io̍h-phín

Wikipedia (chū-iû ê pek-kho-choân-su) beh kā lí kóng...
跳至導覽 跳至搜尋
Chit phiⁿ bûn-chiuⁿ m̄-sī teh kóng Io̍h-bu̍t.
Io̍h-phín

Io̍h-phín (藥品) sī the̍h-lâi chò chín-toàn, tī-jú, tī-liâu ia̍h ī-hông chi̍t-pēⁿ ê io̍h-bu̍t.[1][2][3] Io̍h-bu̍t tī-liâui-ha̍k ê tiōng-iàu khoân-chat, che ài óa-khò io̍h-lí-ha̍k ê chhî-sio̍k chìn-pō͘ kap io̍h-ha̍k ê sek-tòng khòng-chè.

Io̍h-phín ū chē-chē hun-lūi hong-sek. Chiàu io̍h-phín kám ū pī koán-chè, ē-tàng pun chò chhú-hng io̍h-phín kap it-poaⁿ io̍h-phín nn̄g lūi.

  1. Definition and classification of Drug or Pharmaceutical Regulatory aspects of drug approval Accessed 30 December 2013.
  2. US Federal Food, Drug, and Cosmetic Act, SEC. 210., (g)(1)(B). Accessed 17 August 2008.
  3. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Article 1. Published 31 March 2004. Accessed 17 August 2008.